Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Research Tools
Calendars
Economic Indicators
Calculators
Education
About Us
Working with TipRanks
Follow Us
Galectin Therapeutics Inc (GALT)
NASDAQ:GALT
Galectin Therapeutics (GALT) Stock Price & Analysis
528 Followers
GALT Stock Chart & Stats
Day’s Range$0 - $0
52-Week Range$1.28 - $3.74
Previous Close$3.73
Volume931.16K
Average Volume (3M)96.91K
Market Cap
$230.90M
Enterprise Value$205.24M
Total Cash (Recent Filing)$25.66M
Total Debt (Recent Filing)$0.00
Price to Earnings (P/E)-5.0
Beta0.69
Next Earnings
May 13, 2024EPS Estimate
-$0.16Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-0.74
Shares Outstanding61,903,672
10 Day Avg. Volume233,552
30 Day Avg. Volume96,907
Standard Deviation0.24
R-Squared0.04
Alpha-0.00194
Financial Highlights & Ratios
Price to Book (P/B)-3.70
Price to Sales (P/S)N/A
Price to Cash Flow (P/CF)-12.30
P/FCF Ratio0.00
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross Profit10.00T>
Enterprise Value/Ebitda-5.37
Forecast
1Y Price Target
$11.00Price Target Upside194.91% Upside
Rating ConsensusModerate Buy
Number of Analyst Covering1
Galectin Therapeutics News
Ownership Overview
39.04% Insiders
3.83% Mutual Funds
4.72% Other Institutional Investors
52.40% Public Companies and
Individual Investors
Risk Analysis
Main Risk Category
Finance & CorporateFinancial and accounting risks. Risks related to the execution of corporate activity and strategy
GALT FAQ
What was Galectin Therapeutics Inc’s price range in the past 12 months?
Galectin Therapeutics Inc lowest stock price was $1.28 and its highest was $3.74 in the past 12 months.
What is Galectin Therapeutics Inc’s market cap?
Currently, no data Available
When is Galectin Therapeutics Inc’s upcoming earnings report date?
Galectin Therapeutics Inc’s upcoming earnings report date is May 13, 2024 which is in 24 days.
How were Galectin Therapeutics Inc’s earnings last quarter?
Galectin Therapeutics Inc released its earnings results on Mar 29, 2024. The company reported -$0.16 earnings per share for the quarter, missing the consensus estimate of -$0.1 by -$0.06.
Is Galectin Therapeutics Inc overvalued?
According to Wall Street analysts Galectin Therapeutics Inc’s price is currently Undervalued.
Does Galectin Therapeutics Inc pay dividends?
Galectin Therapeutics Inc does not currently pay dividends.
What is Galectin Therapeutics Inc’s EPS estimate?
Galectin Therapeutics Inc’s EPS estimate is -$0.16.
How many shares outstanding does Galectin Therapeutics Inc have?
Galectin Therapeutics Inc has 61,903,670 shares outstanding.
What happened to Galectin Therapeutics Inc’s price movement after its last earnings report?
Galectin Therapeutics Inc reported an EPS of -$0.16 in its last earnings report, missing expectations of -$0.1. Following the earnings report the stock price went down -7.143%.
Which hedge fund is a major shareholder of Galectin Therapeutics Inc?
Currently, no hedge funds are holding shares in GALT
---
Galectin Therapeutics Stock Smart Score
Neutral
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Moderate Buy
Average Price Target:
$11.00 (194.91% Upside)
$11.00 (194.91% Upside)
Blogger Sentiment
Bullish
GALT Sentiment 100%
Sector Average 71%
Sector Average 71%
Insider Transactions
Bought Shares
Worth $890.0 over
the Last 3 Months
the Last 3 Months
Crowd Wisdom
Positive
Last 7 Days ▲ 2.6%
Last 30 Days ▲ 0.3%
Last 30 Days ▲ 0.3%
News Sentiment
Neutral
Bullish news 50%
Bearish news 50%
Bearish news 50%
Technicals
SMA
Positive
20 days / 200 days
Momentum
85.57%
12-Months-Change
Fundamentals
Return on Equity
―
Trailing 12-Months
Asset Growth
32.49%
Trailing 12-Months
Company Description
Galectin Therapeutics Inc
Galectin Therapeutics, Inc. is a biotechnology company, which engages in drug research and development to create new therapies for fibrotic disease, severe skin disease, and cancer. Its programs targets the development of carbohdrate molecules which offers offer alternative options to larger market segments. The company was founded by James C. Czirr and Anatole A. Klyosov on July 10, 2000 and is headquartered in Norcross, GA.
---
GALT Stock 12 Months Forecast
Average Price Target
$11.00
▲(194.91% Upside)
Technical Analysis
Best Analysts Covering GALT
1 Year
1 Year Success Rate
11/19 ratings generated profit
1 Year Average Return
+19.03%
reiterated a buy rating 18 days ago
Copying Ed Arce's trades and holding each position for 1 Year would result in 57.89% of your transactions generating a profit, with an average return of +19.03% per trade.
---